Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Buy
63
IMRN Quote, Financials, Valuation and Earnings
Last price:
$2.24
Seasonality move
:
17.99%
Day range:
$1.89 - $2.22
52-week range:
$1.59 - $5.96
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.63x
P/B ratio:
1.37x
Volume:
20.5K
Avg. volume:
6K
1-year change:
7.37%
Market cap:
$11.7M
Revenue:
$3.2M
EPS (TTM):
-$0.80
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Immuron has 143.98% upside to fair value with a price target of -- per share.
IMRN vs. S&P 500
-
Over the past 5 trading days, Immuron has overperformed the S&P 500 by 6.18% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Immuron does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Immuron has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Immuron reported revenues of --.
Earnings Growth
-
Immuron has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Immuron reported earnings per share of --.
Enterprise value:
3.9M
EV / Invested capital:
--
Price / LTM sales:
3.63x
EV / EBIT:
--
EV / Revenue:
1.21x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$2.2M
Return On Assets:
-35.51%
Net Income Margin (TTM):
-141.8%
Return On Equity:
-40.9%
Return On Invested Capital:
-40.9%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-08 | 2024-01-08 | 2024-01-08 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3M | $19.3M | $16.3M | $13.5M | $9.8M | |
| Total Assets | $4.3M | $20.3M | $17.1M | $14.6M | $10.4M | |
| Current Liabilities | $354.8K | $842.9K | $1M | $1.5M | $1.8M | |
| Total Liabilities | $383.6K | $870.1K | $1.2M | $1.6M | $1.9M | |
| Total Equity | $3.9M | $19.5M | $15.9M | $13M | $8.5M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-08 | 2024-01-08 | 2024-01-08 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
IMRN
Sector
Market Cap
$11.7M
$48.9M
Price % of 52-Week High
34.39%
49.34%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
7.37%
-30.56%
Beta (5-Year)
1.376
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$1.91
200-day SMA
Sell
Level
$2.33
Bollinger Bands (100)
Sell
Level
1.88 - 2.58
Chaikin Money Flow
Sell
Level
-118.2M
20-day SMA
Buy
Level
$2.00
Relative Strength Index (RSI14)
Buy
Level
53.63
ADX Line
Buy
Level
26.85
Williams %R
Neutral
Level
-33.4095
50-day SMA
Buy
Level
$1.95
MACD (12, 26)
Sell
Level
-0.03
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
349.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.9554)
Sell
CA Score
(Annual)
Level (-0.3488)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (4.5387)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Stock Forecast FAQ
In the current month, IMRN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The IMRN average analyst price target in the past 3 months is --.
-
Where Will Immuron Stock Be In 1 Year?
According to analysts, the consensus estimate is that Immuron share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Immuron?
Analysts are divided on their view about Immuron share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Immuron is a Sell and believe this share price will drop from its current level to --.
-
What Is Immuron's Price Target?
The price target for Immuron over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is IMRN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Immuron is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of IMRN?
You can purchase shares of Immuron via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Immuron shares.
-
What Is The Immuron Share Price Today?
Immuron was last trading at $2.24 per share. This represents the most recent stock quote for Immuron. Yesterday, Immuron closed at $2.05 per share.
-
How To Buy Immuron Stock Online?
In order to purchase Immuron stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
